Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05353283 · ClinicalTrials.gov registry record · NA
PrEP Point-of-Care Brief-Intervention for Adherence Among Young Men Who Have Sex With Men
A NA study of Risk Reduction, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 1
- Study location
NCT05353283 is a NA study of Risk Reduction that has completed, run by University of California, San Francisco. The registered enrollment target is 63 participants, below the 3,694-participant average among 13 other Risk Reduction trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05353283, a NA study of Risk Reduction, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
Despite advances in HIV prevention, the HIV incidence among young men who have sex with men (YMSM) is increasing, threatening to derail achievement of the United States End the HIV Epidemic goals. Although, pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention method, adherence was sufficiently low to comprise efficacy among a high proportion of YMSM in multiple clinical trials and demonstration projects. In this study, the investigators will leverage a novel urine point-of-care drug-level test for PrEP adherence, to both enhance and target motivational-interviewing-based adherence counseling among YMSM, with the goal of preventing HIV infections among this critically at-risk group.
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing Counselling
- DEVICE Point-of-care Urine Tenofovir Measurement
Study Locations (1)
California
- University of California, San Francisco/San Francisco General Hospital - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2025-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05353283
The ClinicalTrials.gov registry entry for NCT05353283 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,694-participant average among 13 other Risk Reduction trials with a reported enrollment target (98% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Risk Reduction appearing as the primary indexed condition, and to 2 interventions - of which Motivational Interviewing Counselling is the first listed.
NCT05353283 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05353283 about?
NCT05353283 is a clinical study titled "PrEP Point-of-Care Brief-Intervention for Adherence Among Young Men Who Have Sex With Men". Despite advances in HIV prevention, the HIV incidence among young men who have sex with men (YMSM) is increasing, threatening to derail achievement of the United States End the HIV Epidemic goals. Although, pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention method, adherence was su...
What is the current status of trial NCT05353283?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2023-09-01. Estimated completion is 2025-07-01.
What conditions does trial NCT05353283 study?
This clinical trial studies the following conditions: Risk Reduction.
What interventions are being tested in trial NCT05353283?
The interventions under investigation include: Motivational Interviewing Counselling (BEHAVIORAL), Point-of-care Urine Tenofovir Measurement (DEVICE).
Who is sponsoring clinical trial NCT05353283?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05353283 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Risk Reduction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tennessee Youth Prepared for Success
ACTIVE NOT RECRUITING · NA
-
Efficacy of Communication Modalities for Promoting Flu Shots
COMPLETED · NA
-
Nature and Health: How Does Lifestyle and Environment Affect Health and Wellness
COMPLETED · NA
-
Electronic Confirmed Versus Conventional Consenting Process: A Randomized Controlled Trial
COMPLETED · NA
-
Building Stronger Allies
COMPLETED · NA
-
Acceptability, Feasibility, and Preliminary Impact of a Web-based, HIV Prevention Toolkit With Cisgender Male Couples in Lima, Peru
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.